Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Adherent Placenta (TAP)
NCT02329756Phase 3Withdrawn
- Sponsor
- Baylor College of Medicine
- Start
- Dec 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in placenta accreta (PAS), sponsored by Baylor College of Medicine. Planned start Dec 2018; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
placenta accreta (PAS)
Beyond the preview
Go deeper on NCT02329756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02329756.